Cleared Traditional

CK-NAC REAGENT (K852000) - FDA 510(k) Clearance

Class II Chemistry device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K852000 · Alpkem Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1985
Decision
23d
Days
Class 2
Risk

K852000 is an FDA 510(k) clearance for the CK-NAC REAGENT. Classified as Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes (product code CGS), Class II - Special Controls.

Submitted by Alpkem Corp. (Clackamas, US). The FDA issued a Cleared decision on May 30, 1985 after a review of 23 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1215 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Alpkem Corp. devices

Submission Details

510(k) Number K852000 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 07, 1985
Decision Date May 30, 1985
Days to Decision 23 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 88d · This submission: 23d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes

All 37
Devices cleared under the same product code (CGS) and FDA review panel - the closest regulatory comparables to K852000.
EMDS TOTAL CK TEST PACK-#67670/95
K855056 · Em Diagnostic Systems, Inc. · Jan 1986
EDC/TITAN GELISO-TOTAL CPK ISOENZYME PROCEDURE
K852392 · Helena Laboratories · Oct 1985
SYSTEMATE CK-MB(NAC-ACTIVATED) ITEM NO. 67205
K852483 · Em Diagnostic Systems, Inc. · Jul 1985
TITAN GEL ISO DOT CPK PROCEDURE
K842755 · Helena Laboratories · Sep 1984
SYSTEMATE CK-TOTAL - 67206
K843271 · Em Diagnostic Systems, Inc. · Sep 1984
SIGMA PROCEDURE 47-UV
K842013 · Sigma Chemical Co. · Jun 1984